临床相关性:Treatment Mechanism

A total of 14 records found

#21568 high Confidence
Subject: Niraparib (PARP inhibitors)
inhibits
Object: PARP1-mediated_ADPRylation_of_DDX21 (Protein modification)
Original: Inhibition of PARP1-mediated ADPRylation of DDX21 by niraparib#mislocalizes#DDX21 to nucleoplasm
🏥 Treatment Mechanism 🧬 DDX21 📄 PMID: 38767454
#21567 high Confidence
Subject: CX5461 (Small molecule inhibitors)
targets
Object: RNAPOL1 (RNA polymerase)
Original: CX5461#disrupts#nucleolar integrity by targeting RNAPOL1
🏥 Treatment Mechanism 🧬 POLR1 📄 PMID: 35673898
#21553 high Confidence
Subject: DHODH (Enzymes)
inhibition_depletes
Object: pyrimidine_pool (Metabolites)
Original: Pharmacological inhibition of DHODH#depleted#the pool of pyrimidines in glioblastoma cells
🏥 Treatment Mechanism 🧬 DHODH 📄 PMID: 33201894
#21427 high Confidence
Subject: Bortezomib (Proteasome inhibitors)
interferes_with
Object: protein_biosynthesis_at_nucleolar_ribosome_biogenesis_stage (Molecular Process)
Original: bortezomib#interferes with#protein biosynthesis at nucleolar ribosome biogenesis stage
🏥 Treatment Mechanism 📄 PMID: 27567537
#20380 high Confidence
Subject: RNA_Polymerase_I_inhibitor (Small molecule inhibitors)
blocks
Object: ribosomal_DNA_transcription (Transcription process)
Original: Small molecule inhibitors of RNA Polymerase I#block#ribosomal DNA transcription
🏥 Treatment Mechanism 🧬 POLR1A 📄 PMID: 24389329
#20379 high Confidence
Subject: CX5461 (Small molecule inhibitors)
disrupts
Object: nucleolar_integrity (Subcellular structure)
Original: CX5461#disrupts#nucleolar integrity by targeting RNAPOL1
🏥 Treatment Mechanism 🧬 POLR1 📄 PMID: 35673898
#20361 high Confidence
Subject: DHODH (Enzymes)
inhibition_impairs
Object: rDNA_transcription (Transcription process)
Original: DHODH inhibition#impaired#rDNA transcription/ leading to nucleolar stress
🏥 Treatment Mechanism 🧬 DHODH 📄 PMID: 33201894
#20360 high Confidence
Subject: Actinomycin_D (Chemotherapy drugs)
induces
Object: reorganization_of_nucleolar_components (Subcellular structural changes)
Original: Actinomycin D (AMD)#induces#reorganization of nucleolar components by inhibiting rRNA synthesis
🏥 Treatment Mechanism 📄 PMID: 29190286
#18637 middle Confidence
Subject: Dopamine_agonist (drug)
affects
Object: hormone_release (Molecular Process)
Original: Dopamine agonist#affects#hormone synthesis/ release/ and degradation in PRL-secreting adenoma cells
🏥 Treatment Mechanism 📄 PMID: 3748874
#18636 middle Confidence
Subject: Dopamine_agonist (drug)
affects
Object: hormone_synthesis (Molecular Process)
Original: Dopamine agonist#affects#hormone synthesis/ release/ and degradation in PRL-secreting adenoma cells
🏥 Treatment Mechanism 📄 PMID: 3748874
#16792 middle Confidence
Subject: inhibition_of_PARylation_of_DDX21 (Protein modification)
mislocalizes
Object: DDX21_to_nucleoplasm (Protein subcellular localization)
Original: Inhibition of PARP1-mediated ADPRylation of DDX21 by niraparib#mislocalizes#DDX21 to nucleoplasm
🏥 Treatment Mechanism 🧬 DDX21 📄 PMID: 38767454
#15987 middle Confidence
Subject: Dopamine_agonist (drug)
affects
Object: hormone_degradation (Molecular Process)
Original: Dopamine agonist#affects#hormone synthesis/ release/ and degradation in PRL-secreting adenoma cells
🏥 Treatment Mechanism 📄 PMID: 3748874
#4940 middle Confidence
Subject: Treatment (Therapeutic interventions)
reduces
Object: granule_size (Cellular substructure)
Original: Treatment#reduces#volume density of rough ER and granule size
🏥 Treatment Mechanism 📄 PMID: 3748874
#4939 middle Confidence
Subject: Treatment (Therapeutic interventions)
reduces
Object: volume_density_of_rough_ER (Cellular substructure)
Original: Treatment#reduces#volume density of rough ER and granule size
🏥 Treatment Mechanism 📄 PMID: 3748874